Glioma – Life with Disease

Go back

Glioma is a type of tumor that develops from the supportive cells in the brain or spinal cord, affecting thousands of people each year and presenting unique challenges for patients and their families.

Understanding the Prognosis of Glioma

When someone receives a glioma diagnosis, one of the first questions that comes to mind is about the future and what to expect. The prognosis, or the likely outcome of the disease, varies greatly depending on several factors. These include the type of glioma, its grade, the location in the brain or spinal cord, and the person’s overall health at the time of diagnosis[2].

The grade of a glioma is particularly important in understanding prognosis. Grades range from 1 to 4, with grade 1 being the slowest growing and grade 4 being the most aggressive[2]. Low-grade gliomas (grades 1 and 2) tend to grow more slowly and may be controlled for many years with appropriate treatment. People with low-grade gliomas can have a median survival of 5 to 7 years[16]. Some patients with these slower-growing tumors live much longer, especially when the tumor is caught early and can be treated effectively.

High-grade gliomas (grades 3 and 4), on the other hand, grow much more quickly and are more difficult to treat. Glioblastoma, the most aggressive type classified as grade 4, presents the most serious prognosis. The median survival for glioblastoma is typically between 12 and 18 months[16], though this can vary. Some individuals respond better to treatment than others, and ongoing research continues to seek ways to extend survival and improve quality of life.

⚠️ Important
Statistics about survival are helpful for understanding general patterns, but they cannot predict exactly what will happen to any individual person. Every patient’s situation is unique, and your healthcare team is the best source of information about your personal prognosis. Treatment advances continue to improve outcomes, and some patients live much longer than average survival times suggest.

Molecular and genetic features of the tumor also play a crucial role in prognosis. For example, gliomas with mutations in the IDH gene (a permanent change in a specific gene) generally have a better outlook than those without this mutation[5]. Similarly, certain genetic markers like 1p/19q codeletion in oligodendrogliomas are associated with better treatment response and longer survival[5].

Age and overall health status matter significantly as well. Younger patients and those in better physical condition at the time of diagnosis tend to have better outcomes[16]. This is partly because younger, healthier individuals can often tolerate more intensive treatments and recover more effectively from surgery and other therapies.

How Gliomas Progress Naturally

Understanding how gliomas develop and grow when left untreated helps explain why timely treatment is so important. Gliomas begin when glial cells, which are the supportive cells that surround and help nerve cells in the brain, start growing abnormally[2]. These cells normally have important jobs in keeping the brain functioning properly, but when they grow out of control, they form tumors.

Low-grade gliomas often start growing slowly and may not cause noticeable symptoms at first. However, over time, even low-grade tumors can gradually increase in size and begin pressing on surrounding brain tissue. As they grow, they can interfere with normal brain function. Without treatment, low-grade gliomas have the potential to transform into high-grade gliomas, becoming more aggressive and harder to treat[2].

High-grade gliomas grow much more rapidly from the start. These tumors are infiltrative, meaning they don’t have clear boundaries and their cells spread into nearby healthy brain tissue[3]. This spreading nature makes them particularly challenging because the tumor cells mix with normal brain cells, making complete removal difficult.

As a glioma grows, it takes up space inside the skull, which is a fixed, enclosed space. This leads to increased pressure inside the head, known as increased intracranial pressure[8]. The growing tumor can also press on specific areas of the brain, disrupting their function and causing various symptoms depending on which part of the brain is affected.

Gliomas generally do not spread outside the brain and spinal cord to other parts of the body through the bloodstream, which is different from many other types of cancer[8]. However, they can spread through the cerebrospinal fluid, the liquid that surrounds the brain and spinal cord, potentially causing additional tumors in other areas of the central nervous system[8].

Possible Complications

Living with a glioma can bring various complications, some related to the tumor itself and others to the treatments used to fight it. Understanding these potential complications helps patients and families prepare and know what symptoms to watch for.

One of the most serious complications is seizures, which occur in many people with gliomas[1][2]. Seizures happen when abnormal electrical activity spreads through the brain, and they can range from brief episodes of confusion or staring to full-body convulsions. The tumor can irritate brain tissue and disrupt normal electrical patterns, triggering these seizures even in people who have never had them before.

Increased pressure inside the skull is another significant complication. As the tumor grows, it occupies more space and can block the normal flow of cerebrospinal fluid. This increased pressure can cause persistent headaches, nausea, vomiting, and vision problems[1]. In severe cases, it can lead to brain damage if not addressed promptly.

Neurological deficits can develop when the tumor damages or presses on important areas of the brain. These might include weakness or numbness on one side of the body, difficulty with balance and coordination, trouble speaking or understanding language, memory problems, or changes in personality and mood[2]. The specific problems depend on where in the brain the tumor is located.

Cognitive changes are common and can be particularly distressing. People may experience difficulty with thinking, learning, remembering information, or concentrating[2]. These cognitive issues can affect work, relationships, and daily activities. Some people also experience emotional changes, including depression and anxiety[2], which are both direct effects of the tumor on brain function and understandable emotional responses to the diagnosis.

Fatigue is one of the most common and challenging complications. This is not ordinary tiredness but a persistent, overwhelming exhaustion that doesn’t improve with rest[17]. Fatigue can result from the tumor itself, from treatments like chemotherapy and radiation, or from the body’s overall response to dealing with cancer.

Vision problems can occur when gliomas affect areas of the brain involved in processing visual information or when they directly involve the optic nerves[1][8]. These might include blurred vision, double vision, or loss of peripheral vision.

⚠️ Important
Treatment-related complications can also occur. Surgery carries risks such as infection, bleeding, or damage to healthy brain tissue. Radiation therapy can cause fatigue and skin changes in the treated area, and sometimes delayed effects months or years later. Chemotherapy can cause nausea, fatigue, increased infection risk, and other side effects. Your healthcare team will monitor you closely and provide treatments to manage these side effects.

Impact on Daily Life

A glioma diagnosis and its treatment can profoundly affect every aspect of daily living. Understanding these impacts can help patients and families adapt and find strategies to maintain the best possible quality of life.

Physical activities may become more challenging. Depending on where the tumor is located and how it affects brain function, people might experience weakness, poor coordination, or balance problems that make walking, climbing stairs, or performing routine tasks more difficult[2]. Some people need to use assistive devices like canes or walkers for safety. Driving may need to be temporarily or permanently stopped, especially if someone is having seizures or taking medications that affect alertness.

Work and school can be significantly impacted. Cognitive changes such as difficulty concentrating, memory problems, or slower processing of information can make it hard to perform job duties or keep up with coursework[2]. Fatigue can make it impossible to work full days or full weeks. Some people need to reduce their hours, change positions, take medical leave, or stop working altogether, which can create financial stress in addition to the emotional loss of a valued role.

Social relationships and activities often change. Some people feel self-conscious about physical changes or cognitive difficulties and may withdraw from social situations. Others find it hard to explain their condition to friends and acquaintances. The fatigue and unpredictability of symptoms can make it difficult to make and keep plans, leading to social isolation. Personality changes caused by the tumor can strain even close relationships when family and friends struggle to understand why the person seems different.

Hobbies and recreational activities may need to be modified or given up, at least temporarily. Activities requiring fine motor skills, physical stamina, or complex thinking might become too difficult. This loss of enjoyable activities can affect emotional well-being and sense of identity. However, many people find ways to adapt their hobbies or discover new ones that work within their current abilities.

Emotional well-being is significantly affected. The uncertainty about the future, the stress of treatments, and the changes in abilities and lifestyle can lead to depression and anxiety[2][23]. These are not signs of weakness but normal responses to a serious illness. Mood changes can also result directly from the tumor’s effects on brain areas that regulate emotions.

Family roles and dynamics shift. If the person with glioma was the primary breadwinner, caregiver for children or elderly parents, or household manager, other family members must take on these responsibilities. Spouses may become caregivers, which can be physically and emotionally demanding. Children may need to take on more household duties or cope with having a seriously ill parent.

Financial concerns add another layer of stress. Medical bills, lost income from inability to work, costs of medications and supportive care, and expenses for home modifications or equipment can create significant financial burden. Navigating insurance coverage and seeking financial assistance programs often becomes necessary.

Practical strategies can help manage daily life impacts. Breaking tasks into smaller steps, using calendars and reminders for memory problems, scheduling important activities during times of highest energy, and accepting help from others are all useful approaches[20]. Physical therapy, occupational therapy, and speech therapy can help people maintain or regain abilities. Counseling or support groups provide emotional support. Some people find that adjusting expectations and focusing on what they can do, rather than what they’ve lost, helps maintain a sense of purpose and quality of life.

Support for Families and Clinical Trials

Family members play a crucial role in supporting someone with glioma, and understanding clinical trials is an important part of that support. Clinical trials are research studies that test new treatments or new ways of using existing treatments to find better options for glioma patients.

Families should understand that clinical trials are not just “last resort” options but are an important avenue that can provide access to cutting-edge treatments not yet available to the general public. Experts recommend that people with glioma consider available clinical trials as part of their treatment planning[19]. Many major cancer centers actively conduct glioma clinical trials investigating new surgical techniques, radiation methods, chemotherapy drugs, targeted therapies, and immunotherapy approaches.

Family members can help by learning about clinical trials alongside the patient. This involves understanding what clinical trials are, how they work, and what participation involves. Clinical trials have specific eligibility criteria based on factors like tumor type, grade, previous treatments, overall health, and molecular features of the tumor. Not every trial is appropriate for every patient, and doctors can help determine which trials might be suitable options.

Helping to search for clinical trials is a practical way families can contribute. Resources exist specifically for finding brain tumor clinical trials. Families can work with the patient’s healthcare team to identify potentially appropriate trials and gather information about them. Questions to ask about any clinical trial include what the trial is testing, what treatments are involved, what side effects might occur, how long the trial lasts, what monitoring is required, and whether it requires travel to a different treatment center.

Families should help patients understand that participation in clinical trials is always voluntary. Patients can decide not to participate or can leave a trial at any time without affecting their access to standard treatment. Clinical trials have strict ethical guidelines and oversight to protect participants.

The decision to participate in a clinical trial involves weighing potential benefits against possible risks and inconveniences. Benefits might include access to new treatments, close monitoring by a research team, and the opportunity to contribute to advancing medical knowledge. Possible drawbacks might include unknown side effects, additional appointments and tests, travel requirements, and the possibility of receiving a placebo or less effective treatment if the trial involves comparison groups.

Families can support the patient through the clinical trial process by helping with transportation to appointments, tracking symptoms and side effects, attending medical visits, managing the additional paperwork and scheduling involved, and providing emotional support throughout the experience.

Beyond clinical trials, families need support for themselves as well. Caring for someone with a serious illness is physically and emotionally demanding. Family members should not neglect their own health and well-being. Seeking support through counseling, caregiver support groups, or talking with friends and other family members is important. Taking breaks from caregiving, even brief ones, helps prevent burnout.

Practical support for families includes learning about the disease, understanding what to expect, communicating openly with the healthcare team, organizing medical information and appointments, and connecting with resources like patient advocacy organizations and social services. Many hospitals and cancer centers have social workers, patient navigators, and support services specifically designed to help families cope with the challenges of brain tumor treatment.

Families should also be prepared for difficult conversations about goals of care, quality of life priorities, and end-of-life planning. While these conversations are hard, having them earlier rather than later allows the patient’s wishes to guide care decisions and can reduce stress and conflict during difficult times.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Temozolomide – A chemotherapy medication used as standard treatment following surgery and radiation for gliomas, particularly glioblastoma
  • Carmustine wafers – Implantable wafers placed in the brain during surgery that release chemotherapy directly to the tumor site
  • Avapritinib – A targeted therapy drug approved by the FDA for certain genetic mutations, being investigated for high-grade gliomas with PDGFRA mutations

Ongoing Clinical Trials on Glioma

  • Study on Lutetium (177Lu) Zadavotide Guraxetan for Patients with Recurrent Grade 3 and Grade 4 Glioma

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Norway
  • Study on the Safety and Effectiveness of Vorasidenib and Temozolomide for Patients with IDH1 or IDH2 Mutant Glioma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria France Germany Italy The Netherlands Spain
  • Study on the Safety and Effectiveness of Sirolimus for Treating High-Grade Glioma in Children

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study of Abemaciclib and Temozolomide for Children and Young Adults with Newly Diagnosed High-Grade Glioma After Radiotherapy

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark France Italy The Netherlands Romania +1
  • Study of WT1 LAMP mRNA DC Immunotherapy for Children with High-Grade Glioma and Diffuse Intrinsic Pontine Glioma

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study Comparing Fluciclovine (18F) and Fluoroethyltyrosine F-18 PET Scans in Patients with New or Recurrent Brain Tumors and Brain Metastases

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Germany
  • Study of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Italy Spain
  • Study of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Spain
  • Study of Nivolumab with Chemotherapy for Children and Teenagers with Refractory or Relapsing Solid Tumors or Lymphoma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France
  • Study of Cobolimab and Dostarlimab for Children and Young Adults with Newly Diagnosed or Relapsed/Refractory Tumors

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Czechia Denmark France Germany Italy Spain

References

https://www.mayoclinic.org/diseases-conditions/glioma/symptoms-causes/syc-20350251

https://my.clevelandclinic.org/health/diseases/21969-glioma

https://www.ncbi.nlm.nih.gov/books/NBK441874/

https://braintumourresearch.org/pages/types-of-brain-tumours-glioma?srsltid=AfmBOopslMT6LRKMnCJKwWNIbiMIHVT2kPoAlKcytyvxFnceOWE2FTUN

https://www.cancerresearchuk.org/about-cancer/brain-tumours/types/glioma-adults

https://www.abta.org/tumor_types/glioma/

https://www.tgh.org/institutes-and-services/conditions/glioma

https://en.wikipedia.org/wiki/Glioma

https://www.mayoclinic.org/diseases-conditions/glioma/diagnosis-treatment/drc-20350255

https://my.clevelandclinic.org/health/diseases/21969-glioma

https://www.mskcc.org/cancer-care/types/glioma/glioma-treatment

https://pmc.ncbi.nlm.nih.gov/articles/PMC4852970/

https://www.brighamandwomens.org/cancer/Glioma/glioma-treatment-options-and-grading

https://www.neurosurgery.columbia.edu/patient-care/conditions/gliomas

https://www.drugtargetreview.com/news/157827/new-research-offers-hope-for-high-grade-glioma-treatment/

https://pmc.ncbi.nlm.nih.gov/articles/PMC9833488/

https://braintumor.org/news/7-tips-to-manage-fatigue-as-a-person-living-with-a-brain-tumor/

https://www.aaroncohen-gadol.com/en/patients/glioma/survival/end-of-life

https://www.abta.org/mindmatters/what-to-do-after-a-glioblastoma-diagnosis-5-first-steps-for-patients-and-families/

https://pmc.ncbi.nlm.nih.gov/articles/PMC8146925/

https://www.mygliomaguide.com/managing-glioma

https://braintumor.org/news/lets-talk-about-glioblastoma/

https://www.cancerresearchuk.org/about-cancer/brain-tumours/living-with/coping

FAQ

What causes gliomas?

The exact causes of gliomas are not fully known. Genetic changes in glial cells cause gliomas, but doctors don’t always understand why these changes occur. The best-known risk factor is exposure to ionizing radiation, including radiation from CT scans. Some hereditary disorders like neurofibromatosis and tuberous sclerosis complex can predispose people to developing gliomas. However, most gliomas occur in people without clear risk factors.

How is a glioma diagnosed?

Glioma diagnosis usually starts with a neurological examination to assess brain function, followed by imaging tests. MRI is the most commonly used imaging test to look for signs of a brain tumor. Sometimes a CT scan or PET scan may also be used. To confirm the diagnosis and determine the exact type of glioma, a biopsy is performed to remove a sample of tissue for testing. This can be done through surgery or through a needle biopsy procedure. The tissue is then examined in a laboratory where doctors analyze the cells, their appearance, and their molecular and genetic features.

Are all gliomas cancerous?

Not all gliomas are cancerous. Some grow slowly and aren’t considered cancers, particularly grade 1 gliomas. Others are considered malignant (cancerous), especially high-grade gliomas like grades 3 and 4. The grade of the glioma, which describes how abnormal the cells look and how quickly they grow, helps determine whether it’s cancerous. Even slow-growing gliomas require monitoring and often treatment because they can cause problems by pressing on brain tissue or can potentially transform into more aggressive forms over time.

Can gliomas spread to other parts of the body?

Gliomas generally do not spread outside the brain and spinal cord to other parts of the body through the bloodstream, which is different from many other types of cancer. However, they can spread through the cerebrospinal fluid that surrounds the brain and spinal cord, potentially causing additional tumors in other areas of the central nervous system. This is sometimes called “drop metastases” when it affects the spinal cord.

What treatment options are available for glioma?

Glioma treatment requires a multidisciplinary approach and typically includes a combination of surgery, radiation therapy, and chemotherapy. Surgery aims to remove as much of the tumor as safely possible. Radiation therapy uses targeted radiation to kill remaining cancer cells. Chemotherapy, which can be given as pills or infusions, also works to kill cancer cells. For some gliomas, targeted treatments that address specific genetic mutations may be available. The specific treatment plan depends on the type and grade of glioma, its location, molecular features, and the patient’s overall health. Clinical trials may offer access to new treatments not yet widely available.

🎯 Key takeaways

  • Gliomas are the most common type of primary brain tumor in adults, originating from the brain’s supportive glial cells
  • The grade of a glioma (1 through 4) significantly impacts prognosis, with lower grades growing more slowly and higher grades being more aggressive
  • Molecular markers like IDH mutations and 1p/19q codeletion provide important information about prognosis and treatment options
  • Early detection and treatment of low-grade gliomas may slow or prevent transformation into more aggressive high-grade tumors
  • Fatigue is one of the most common and debilitating complications, affecting nearly every aspect of daily life
  • Clinical trials offer access to cutting-edge treatments and are recommended for consideration by leading cancer organizations
  • Treatment typically requires a combination of surgery, radiation, and chemotherapy tailored to the individual patient
  • Family support is crucial, and families should also seek support for themselves as caregiving can be physically and emotionally demanding